Pm. Sullivan et al., TYPE-III HYPERLIPOPROTEINEMIA AND SPONTANEOUS ATHEROSCLEROSIS IN MICERESULTING FROM GENE REPLACEMENT OF MOUSE APOE WITH HUMAN APOE-ASTERISK-2, The Journal of clinical investigation, 102(1), 1998, pp. 130-135
To study isoform-specific effects of apolipoprotein E (apoE) in vivo,
we generated mice with a human APOE2 allele in place of the mouse Apo
e gene via targeted gene replacement in embryonic stem cells. Mice exp
ressing human apoE2 (2/2) have virtually all the characteristics of ty
pe III hyperlipoproteinemia. Their plasma cholesterol and triglyceride
levels are both twice to three times those in (normolipidemic) mice t
hat are expressing human apoE3 (3/3) made in an identical manner. The
2/2 mice are markedly defective in clearing beta-migrating VLDL partic
les, and spontaneously develop atherosclerotic plaques, even on a regu
lar diet. An atherogenic diet, high in fat and cholesterol, exacerbate
s development of atherosclerosis and xanthomas in the 2/2 mice. Thus,
comparisons between the 2/2 and 3/3 mice unequivocally demonstrate tha
t a single amino acid difference (Arg158 Cys) in the apoE protein is s
ufficient to cause type III HLP and spontaneous atherosclerosis in mic
e.